Lv1
10 积分 2026-07-30 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已完结
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
1个月前
已完结
Opportunities and challenges of targeting cGAS–STING in cancer
1个月前
已完结
Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242
1个月前
已完结
Drug development in schizophrenia: are glutamatergic targets still worth aiming at?
1个月前
已完结
Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders
1个月前
已完结
A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia
1个月前
已完结
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia
1个月前
已完结
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
1个月前
已完结
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study
1个月前
已完结
皖公网安备34019202002308
